Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | BMY | AMGN | GILD | VRTX |
| Company | Lineage Cell Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1500 | 44.82 | 266.15 | 65.66 | 395.16 |
| High | 1.1500 | 44.82 | 266.15 | 65.66 | 395.16 |
| Low | 1.1500 | 44.82 | 266.15 | 65.66 | 395.16 |
| Last | 1.1500 | 44.82 | 266.15 | 65.66 | 395.16 |
| Change | +0.0400 | +0.12 | -3.23 | +0.39 | -2.54 |
| % Change | +3.60% | +0.27% | -1.20% | +0.60% | -0.64% |
| Volume | 134 | 36,328 | 3,185 | 5,717 | 440 |
| 20-Day Average Volume | 934,857 | 12,143,092 | 2,035,254 | 6,443,556 | 909,527 |
| Previous Close | 1.1100 | 44.70 | 269.38 | 65.27 | 397.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2835 | 49.47 | 269.79 | 68.30 | 401.16 |
| 20-Day Raw Stochastic | 10.87% | 4.56% | 23.55% | 7.01% | 13.63% |
| 20-Day Relative Strength | 46.17% | 28.98% | 42.04% | 30.60% | 40.98% |
| Weighted Alpha | -15.85 | -34.50 | +7.31 | -23.09 | +13.85 |
| Today's Opinion | 24% Buy | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 8% Sell | 88% Sell | 72% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 56% Buy | 8% Buy | 40% Buy | 88% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/19/24 | -8.40% since 04/19/24 | -1.03% since 04/19/24 | -1.65% since 04/19/24 | +0.22% since 04/19/24 |
| Low | 1.1000 on 04/25/24 | 44.37 on 04/25/24 | 266.15 on 04/26/24 | 65.09 on 04/25/24 | 393.00 on 04/25/24 |
| High | 1.1856 on 04/23/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -12.21% since 03/26/24 | -14.71% since 03/26/24 | -5.54% since 03/26/24 | -9.32% since 03/26/24 | -5.57% since 03/26/24 |
| Low | 1.1000 on 04/25/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 1.6100 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +4.55% since 01/26/24 | -9.82% since 01/26/24 | -14.63% since 01/26/24 | -17.43% since 01/26/24 | -8.14% since 01/26/24 |
| Low | 0.8414 on 02/01/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 | 391.01 on 04/18/24 |
| High | 1.6100 on 03/28/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | unch since 10/26/23 | -15.39% since 10/26/23 | -1.32% since 10/26/23 | -16.36% since 10/26/23 | +9.38% since 10/26/23 |
| Low | 0.8414 on 02/01/24 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 | 341.90 on 11/16/23 |
| High | 1.6100 on 03/28/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 209,273 | 90,596,128 | 144,488,960 | 81,266,176 | 102,789,152 |
| Shares Outstanding, K | 188,534 | 2,026,759 | 536,376 | 1,245,077 | 258,459 |
| Annual Sales | 8,950,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -21,490,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 2,090,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -4,780,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.31 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 03/07/24 | -4.40 on 04/25/24 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | 0.080 on 12/15/03 | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.51 | 14.64 | 9.98 | 29.82 |